Verrica Pharmaceuticals Inc. (VRCA) Misses Q1 EPS by 41c

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) reported Q1 EPS of ($0.41). Revenue for the quarter came in at $5 million.

For earnings history and earnings-related data on Verrica Pharmaceuticals Inc. (VRCA) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Citizens Starts Keel Infrastructure (KEEL) at Market Outperform
• KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook